KCT0005076招募中未知
Clopidogrel versus Aspirin Monotherapy after Percutaneous Coronary Intervention and Standard Dual Antiplatelet Therapy in Patients at High Risk for Recurrent Ischemic Events
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 5,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19?(Year) 至 0No Limit（—）
- 性别
- All
入选标准
- •?over 19 years of age
- •?Patients with high risk of relapse of ischemic events who have been undergoing percutaneous coronary artery intervention using a drug-extraction stent for more than 12 months and undergoing double-anti-blood platelet treatment (if one or more of the following clinical or lesion characteristics are satisfied, patients with single treatment are excluded. Patients who have been receiving double anti-septic platelets for more than 12 months may be subject to study regardless of how long or 12 months have passed since the procedure.)
- •1)clinical characteristic
- •i)Treatment with myocardial infarction
- •ii)drug-treated diabetes
- •2)lesion characteristics: See coronary complex lesion features below
- •?a person who can voluntarily sign a consent form.
- •*Anatomical features of coronary complex lesions are defined as those accompanied by one or more of the following nine.
- •1) Medina classification (1,1/1,0,1/0,1,1) and the opening lesions of the lateral branch can be treated.
- •2) If the target vessel is a chronic completely occlusion lesion (=3 months)
- •3) In the case of unprotected left-wing paper lesions (left-wing journal lesions include non-true branch lesions.)
- •4) In case the inserted stent is longer than 38mm in length
- •5) Coronary artery intervention procedures are performed in two or more major coronary arteries at once due to polyvascular diseases.
- •6) If multiple stents are required (=3 more stent per patient)
- •7) In case of coronary stent re-stenosis lesion
- •8) Severe coronary calculus in angiography
- •9) In the case of left-hand lower limb, left-hand gland, and right-hand artery inlet lesions.
排除标准
- •?In case of hypersensitivity to clinical trial drugs (aspirin or clopidogrel) or a taboo on medication,
- •?Patients requiring continuous anticoagulant treatment
- •?Patients who need to be treated with double anti-blood platelet due to arteriosclerotic diseases other than coronary artery diseases
- •?Patients scheduled to open a blood vessel in the coronary artery
- •?Patients undergoing single treatment
- •?Pregnant women and breastfeeding women
- •?Those who have a life expectancy of less than 2 years or are expected to be less compliant with treatment due to non-heart disease (medical judgment by the investigator)
研究者
相似试验
招募中
不适用
Antiplatelet Strategy after Abbreviated Dual-antiplatelet therapy following New generation coronary stents implantatioDiseases of the circulatory systemKCT0007210Yonsei University Health System, Severance Hospital3,744
进行中（未招募）
1 期
Aspirin versus Aspirin plus Clopidogrel in Patients Undergoing Transcatheter Aortic ValveReplacement: a Randomized Multicenter Studyvalvular aortic stenosis submitted to TAVIMedDRA version: 20.0Level: PTClassification code 10002918Term: Aortic valve stenosisSystem Organ Class: 10007541 - Cardiac disordersEUCTR2018-000608-40-ITAOU DI BOLOGNA POLICLINICO S.ORSOLA-MALPIGHI762
已完成
4 期
SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3Coronary Artery DiseaseNCT04418479Joo-Yong Hahn5,506
招募中
不适用
Prasugrel Monotherapy versus Combination of Clopidogrel plus Aspirin in Stabilized Patients with Acute Coronary Syndrome after Complex High-risk and Indicated Percutaneous Coronary Intervention (PRADO-CHIP)Diseases of the circulatory systemKCT0008033The Catholic University of Korea, Seoul St. Mary's Hospital2,000
进行中（未招募）
不适用
International Study using Clopidogrel and Aspirin for the treatment of Polycythemia Vera. - ISCLAPMedDRA version: 9.1Level: LLTClassification code 10036057Term: Polycythaemia veraPolycythemia VeraEUCTR2007-007801-63-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI